Oncogenetics Group

The Oncogenetics group have three sub-groups working alongside each other: the lab group of scientists and clinical fellows, the data group of scientists and administrators and the clinical group of nurses and clinical fellows. Our principal investigator, Professor Ros Eeles, oversees these groups.

Our group aims to translate laboratory findings about genetic risk factors for cancer into the clinic with a focus on predisposition to prostate cancer.

The Oncogenetics Group aims to translate laboratory findings about genetic risk factors for cancer into the clinic. Our focus is on predisposition to prostate cancer.

The laboratory component of the research programme involves the search for prostate cancer predisposition genes and studies of their mutation spectra, risks and interactions with environmental factors.

The clinical component of the research encompasses risk profiling, targeted screening, prevention and the application of cancer genetics to cancer management. There is close interaction with The Royal Marsden NHS Foundation Trust and, in addition to studies in the management of individuals with a predisposition to prostate cancer, there is a research programme in genetic counselling and integration of cancer genetics into the cancer care pathway.

We have established an uro-genetics clinic to investigate the application of genetic research in prostate cancer predisposition to the clinic. This is in addition to our now long-established specialised carrier clinic for the translational research into and management of individuals with mutations in the genes BRCA1 and BRCA2.

There are also psychosocial studies conducted in collaboration with the Department of Psychological Medicine.

Professor Rosalind Eeles

Group Leader:

Oncogenetics

Professor Rosalind Eeles is searching for genetic variants that increase a person’s risk of prostate cancer and is currently leading clinical trials looking into whether regular screening of men with certain genetic mutations/genetic risk profiles leads to earlier diagnosis.

Researchers in this group

.

Phone: +44 20 3437 6407

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6433

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6069

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

.

Phone: +44 20 8722 4624

Email: [email protected]

Location: Sutton

.

Phone: +44 20 8722 4034

Email: [email protected]

Location: Sutton

.

Phone: +44 20 8722 4586

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6125

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6447

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6403

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6443

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6446

Email: [email protected]

Location: Sutton

.

Phone: 02034376131

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 3506

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6648

Email: [email protected]

Location: Sutton

.

Phone: +44 20 8722 4162

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6449

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6444

Email: [email protected]

Location: Sutton

.

Phone: +44 20 8722 4027

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 3545

Email: [email protected]

Location: Sutton

.

Email: [email protected]

Location: Chelsea

.

Phone: +44 20 3437 6445

Email: [email protected]

Location: Sutton

.

Phone: +44 20 8722 4194

Email: [email protected]

Location: Sutton

.

Phone: +44 20 3437 6711

Email: [email protected]

Location: Sutton

Professor Rosalind Eeles's group have written 50 publications

Most recent new publication 1/11/2008

See all their publications

Recent discoveries from this group

Blood samples in tubes

19/10/24

Doctors could predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best targeted treatment quickly before it spreads – thanks to a new £1.5 million research project harnessing artificial intelligence and cutting-edge genetic analysis.
The container to collect saliva in at home

13/10/24

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, thanks to a new spit test which can be taken at home.
ICR Logo

31/05/24

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one group of men than the current standard blood test, a new study reports.
Professor Ros Eeles

30/04/24

Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen men for prostate cancer and double the number of lives saved.